FDAnews Device Daily Bulletin

Sofregen Medical Acquires SERI Surgical Scaffold Product Line from Allergan

Nov. 14, 2016

Sofregen Medical has purchased the SERI Surgical Scaffold product line from Allergan.

SERI is currently being used for soft tissue support in plastic and reconstructive surgical procedures. Through bio replacement, SERI facilitates neovascularization and native tissue generation over time.

Terms of the deal were not disclosed. — Cynthia Jessup

View today's stories